Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in
Shu-Shong Hsu1, Chun-Jen Huang, He-Hsiung Cheng
1Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.
Abstract:
The effect of anandamide on human osteoblasts is unclear. This study examined the effect of anandamide on viability, apoptosis, mitogen-activated protein kinases (MAPKs) and Ca2+ levels in MG63 osteosarcoma cells. Anandamide at 50-200 microM decreased cell viability via apoptosis as demonstrated by propidium iodide staining and activation of caspase-3. Immunoblotting suggested that anandamide induced expression of ERK, JNK and p38 MAPK. Anandamide-induced cell death and apoptosis were reversed by SB203580, but not by PD98059 and SP600125, suggesting that anandamide's action was via p38 MAPK, but not via ERK and JNK. Anandamide at 1-100 microM induced [Ca2+]i increases. Removal of extracellular Ca2+ decreased the anandamide response, indicating that anandamide induced Ca2+ influx and Ca2+ release. Chelation of intracellular Ca2+ with BAPTA reversed anandamide-induced cell death and p38 MAPK phosphorylation. Collectively, in MG63 cells, anandamide induced [Ca2+]i increases which evoked p38 MAPK phosphorylation. This p38 MAPK phosphorylation subsequently activated caspase-3 leading to apoptosis.
Insights
Anandamide induces apoptosis in human osteosarcoma cells by increasing intracellular calcium and activating p38 MAPK. This pathway leads to caspase-3 activation and cell death, impacting osteoblast research.
Area of Science:
- Cell Biology
- Biochemistry
- Pharmacology
Background:
- The role of anandamide in human osteoblast function remains largely uncharacterized.
- Osteoblasts are crucial for bone formation and remodeling.
- Understanding cellular responses to anandamide is vital for potential therapeutic applications.
Purpose of the Study:
- To investigate the effects of anandamide on human osteosarcoma MG63 cell viability, apoptosis, and intracellular signaling pathways.
- To elucidate the specific mitogen-activated protein kinase (MAPK) pathways involved in anandamide-induced cellular responses.
- To determine the role of intracellular calcium (Ca2+) in anandamide-mediated effects on osteoblasts.
Main Methods:
- MG63 cells were treated with varying concentrations of anandamide.
- Cell viability was assessed using propidium iodide staining.
- Apoptosis was evaluated by caspase-3 activation assays.
- Mitogen-activated protein kinase (MAPK) expression (ERK, JNK, p38) was analyzed via immunoblotting.
- Intracellular Ca2+ ([Ca2+]i) levels were measured.
- Pharmacological inhibitors (SB203580, PD98059, SP600125) and BAPTA were used to probe signaling pathways.
Main Results:
- Anandamide (50-200 microM) decreased cell viability and induced apoptosis, evidenced by caspase-3 activation.
- Anandamide upregulated ERK, JNK, and p38 MAPK expression.
- SB203580, a p38 MAPK inhibitor, reversed anandamide-induced apoptosis, while PD98059 (ERK) and SP600125 (JNK) did not.
- Anandamide (1-100 microM) increased intracellular Ca2+ levels, involving both influx and release.
- Chelation of intracellular Ca2+ with BAPTA inhibited anandamide-induced cell death and p38 MAPK phosphorylation.
Conclusions:
- Anandamide triggers apoptosis in MG63 osteosarcoma cells through a mechanism involving increased intracellular Ca2+.
- The observed calcium increase activates p38 MAPK, which subsequently phosphorylates caspase-3, leading to apoptosis.
- Anandamide's effects are mediated by the p38 MAPK pathway, not ERK or JNK, highlighting a specific signaling cascade in osteosarcoma cells.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
MAPK Signaling Cascades
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
